Koninklijke Philips Goodwill and Intangible Assets 2010-2024 | PHG

Koninklijke Philips goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • Koninklijke Philips goodwill and intangible assets for the quarter ending September 30, 2024 were $14.351B, a 13.81% decline year-over-year.
  • Koninklijke Philips goodwill and intangible assets for 2024 were $14.462B, a 2.27% increase from 2023.
  • Koninklijke Philips goodwill and intangible assets for 2023 were $14.141B, a 2.49% decline from 2022.
  • Koninklijke Philips goodwill and intangible assets for 2022 were $14.502B, a 14.21% decline from 2021.
Koninklijke Philips Annual Goodwill and Intangible Assets
(Millions of US $)
2024 $14,462
2023 $14,141
2022 $14,502
2021 $16,903
2020 $12,578
2019 $13,574
2018 $14,281
2017 $12,493
2016 $13,777
2015 $13,565
2014 $13,992
2013 $12,972
2012 $13,734
2011 $15,338
2010 $16,245
2009 $16,070
Koninklijke Philips Quarterly Goodwill and Intangible Assets
(Millions of US $)
2024-06-30 $14,351
2023-06-30 $14,571
2023-03-31
2022-06-30 $16,534
2021-06-30 $16,651
2020-06-30 $13,080
2019-06-30 $13,657
2018-06-30 $13,640
2017-06-30 $10,111
2016-12-31 $13,777
2016-09-30 $13,305
2016-06-30 $13,541
2016-03-31 $13,008
2015-12-31 $13,565
2015-09-30 $13,270
2015-06-30 $13,587
2015-03-31 $14,200
2014-12-31 $13,992
2014-09-30 $13,846
2014-06-30 $13,356
2014-03-31 $13,257
2013-12-31 $12,972
2013-09-30 $13,319
2013-06-30 $13,640
2013-03-31 $14,168
2012-12-31 $13,734
2012-09-30 $13,789
2012-06-30 $14,587
2012-03-31 $14,156
2011-12-31 $15,338
2011-09-30 $14,866
2011-06-30 $14,354
2011-03-31 $15,789
2010-12-31 $16,245
2010-09-30 $15,437
2010-06-30 $16,846
2010-03-31 $16,841
2009-12-31 $16,070
2009-09-30 $16,303
2009-06-30 $16,081
2009-03-31 $15,823
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.053B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.085B 27.79
Boston Scientific (BSX) United States $155.238B 38.86
Stryker (SYK) United States $144.362B 30.18
EssilorLuxottica (ESLOY) France $132.860B 0.00
Medtronic (MDT) Ireland $108.824B 15.89
Lonza Group Ag (LZAGY) Switzerland $52.624B 0.00
Haleon (HLN) United Kingdom $48.259B 27.44
ResMed (RMD) United States $35.183B 26.43
GE HealthCare Technologies (GEHC) United States $32.295B 15.33
Agilent Technologies (A) United States $30.971B 20.46
Terumo (TRUMY) Japan $29.019B 0.00
Zimmer Biomet Holdings (ZBH) United States $20.255B 12.80
Insulet (PODD) United States $18.084B 77.18
Baxter (BAX) United States $15.752B 11.77
Smith & Nephew SNATS (SNN) United Kingdom $12.535B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $7.970B 0.00
Lantheus Holdings (LNTH) United States $7.447B 18.31
Bio-Rad Laboratories (BIO) United States $6.620B 22.38
Prestige Consumer Healthcare (PBH) United States $4.171B 19.90
Perrigo (PRGO) Ireland $3.497B 10.01
ICU Medical (ICUI) United States $3.486B 29.69
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.208B 15.10
Envista Holdings (NVST) United States $2.880B 23.93
GN Store Nord (GNNDY) Denmark $2.068B 17.13
QuidelOrtho (QDEL) United States $1.964B 16.45
LeMaitre Vascular (LMAT) United States $1.778B 39.75
AtriCure (ATRC) United States $1.486B 0.00
Green Thumb Industries (GTBIF) United States $1.374B 21.63
Neogen (NEOG) United States $1.248B 15.97
Kestra Medical Technologies (KMTS) United States $1.220B 0.00
BioLife Solutions (BLFS) United States $1.200B 0.00
AdaptHealth (AHCO) United States $1.184B 11.40
InMode (INMD) Israel $1.013B 9.28
Phibro Animal Health (PAHC) United States $0.789B 12.10
Evolus (EOLS) United States $0.779B 0.00
Curaleaf Holdings (CURLF) Canada $0.637B 0.00
CeriBell (CBLL) United States $0.588B 0.00
Owens & Minor (OMI) United States $0.580B 4.94
Valneva SE (VALN) France $0.549B 0.00
Capricor Therapeutics (CAPR) United States $0.542B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.526B 0.00
Tilray Brands (TLRY) Canada $0.458B 0.00
Cresco Labs (CRLBF) United States $0.442B 0.00
Omeros (OMER) United States $0.418B 0.00
Surmodics (SRDX) United States $0.395B 0.00
SNDL (SNDL) Canada $0.365B 0.00
VAREX IMAGING (VREX) United States $0.359B 15.55
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Verano Holdings (VRNOF) United States $0.296B 0.00
Sanara MedTech (SMTI) United States $0.292B 0.00
Viemed Healthcare (VMD) United States $0.291B 26.32
Aurora Cannabis (ACB) Canada $0.272B 48.40
Sanuwave Health (SNWV) United States $0.264B 0.00
ZimVie (ZIMV) United States $0.261B 15.60
Cerus (CERS) United States $0.258B 0.00
Canopy Growth (CGC) Canada $0.245B 0.00
Quanterix (QTRX) United States $0.233B 0.00
OraSure Technologies (OSUR) United States $0.231B 0.00
High Tide (HITI) Canada $0.194B 0.00
Biote (BTMD) United States $0.190B 4.35
Utah Medical Products (UTMD) United States $0.173B 13.93
Brainsway (BWAY) Israel $0.170B 53.06
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
Organigram Global (OGI) Canada $0.154B 0.00
FitLife Brands (FTLF) United States $0.148B 18.22
Jin Medical (ZJYL) China $0.119B 0.00
TerrAscend (TSNDF) Canada $0.116B 0.00
MacroGenics (MGNX) United States $0.110B 0.00
Exagen (XGN) United States $0.108B 0.00
Agape ATP (ATPC) $0.099B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Fonar (FONR) United States $0.076B 10.70
Jushi Holdings (JUSHF) United States $0.076B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.073B 0.00
Zynex (ZYXI) United States $0.070B 0.00
United Health Products (UEEC) United States $0.064B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Apyx Medical (APYX) United States $0.047B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Rockwell Medical (RMTI) United States $0.042B 61.50
United-Guardian (UG) United States $0.037B 11.28
Safety Shot (SHOT) United States $0.036B 0.00
Nephros (NEPH) United States $0.020B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00